Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for AMINOLEVULINIC ACID HYDROCHLORIDE
- Phase III Clinical Trial Evaluating the Efficacy and Safety of 5-aminolevulinic Acid (5-ALA）
- A Phase I/II, Intra-Patient Dose-Escalation Study of the Selective GlyT1 Inhibitor, Bitopertin for Steroid-Refractory Diamond-Blackfan Anemia.
- Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)
- Effect of Photodynamic Therapy on Skin Microbiome. Single Center Study (PHOMIC-III)
- Radiodynamic Therapy (RDT) With Gliolan in Patients With First Recurrence of Brain Tumor
- Study to Evaluate 5-ALA Combined With CV01 Delivery of Ultrasound in Recurrent High Grade Glioma
- The Role of 5-Aminolevulinic Acid Fluorescence-Guided Surgery in Head and Neck Cancers: a Pilot Trial
- Sonodynamic Therapy With ExAblate System in Glioblastoma Patients
- Fluorescence Imaging of Carcinoma During Breast Conserving Surgery
- Clinical Safety Study on 5-Aminolevulinic Acid (5-ALA) in Children and Adolescents With Supratentorial Brain Tumors
- Photodynamic Therapy for Cutibacterium Acnes (C. Acnes) Decolonization of the Shoulder Dermis
- Conventional Photodynamic Therapy Versus Daylight Photodynamic Therapy for The Treatment of Acne Vulgaris
- Stereotactical Photodynamic Therapy With 5-aminolevulinic Acid (Gliolan®) in Recurrent Glioblastoma
- 5-aminolevulinic Acid In Advanced Malignancies
- Phase I Study in Advanced Malignancies With 5-ALA
- Efficacy of Sunlight Activated Synthetic Porphyrin in COVID-19 Infected Patients
- Gleolan for Visualization of Newly Diagnosed or Recurrent Meningioma
- Portable Measurement of Protoporphyrin IX in the Skin During Photodynamic Therapy
- TMFI Enhances Skin Surface and Epidermal PpIX Fluorescence
- Efficacy and Safety of Painless 5-aminolevulinic Acid Photodynamic Therapy for Moderate and Severe Acne Vulgaris
- Extracorporeal Photopheresis of Patients With Crohn's Disease Using 5-aminolevulinic Acid
- Pharmacokinetics and Safety of ALA in Acne Vulgaris
- A Study to Assess the Safety and Efficacy of 5-aminolevulinic Acid Hydrochloride (5-ALA HCl) and Sodium Ferrous Citrate (SFC) Added on Artemisinin-based Combination Therapy (ACT) in Adult Patients With Uncomplicated Malaria
- Duration of Ameluz Application in Acral Actinic Keratoses Response
- Photodynamic Therapy and Microvesicles
- Photodynamic Therapy-Induced Immune Modulation: Part III
- Aminolevulinic Acid-photodynamic Therapy for Facial Actinic Keratosis Treatment and Prevention
- Vitamin D as a Nutritional Neoadjuvant During Photodynamic Therapy of Basal Cell Carcinoma
- Vitamin D as a Nutritional Neoadjuvant During Photodynamic Therapy of Basal Cell Carcinoma
- Study of Daylight Photodynamic Therapy With Aminolevulinic Acid for Actinic Keratoses
- Daylight Photodynamic Therapy for Actinic Keratosis
- Interest of Fluorescein in Fluorescence-guided Resection of Gliomas (FLEGME)
- Photodynamic Therapy in Treating Patients With Refractory Mycosis Fungoides
- Modification of Extracorporeal Photopheresis in Cutaneous T-cell Lymphoma or Chronic Graft-versus-host Disease
- Photodynamic Therapy Incubation Times for Actinic Keratosis
- Phase 3 Study of Levulan With New Blue Light for AK on the Face or Scalp
- A Clinical Trial of Topical Photodynamic Therapy With 5-aminolevulinic Acid for the Treatment of Actinic Keratosis
- Photodynamic Therapy for Lentigo Maligna Using 5-aminolevulinic Acid Nanoemulsion as a Light Sensitizing Cream
- Efficacy of Iontophoresis-assisted AFL-PDT in Actinic Keratosis
- Efficacy and Safety of Treatment of Actinic Keratoses With Photodynamic Therapy Between MAL Cream and ALA Gel
- Photodynamic Therapy and Vismodegib for Multiple Basal Cell Carcinomas
- 5-Aminolevulinic Acid (5-ALA) to Enhance Visualization of Malignant Tumor
- Microneedle Lesion Preparation Prior to Aminolevulinic Acid Photodynamic Therapy (ALA-PDT) for AK on Face
- Maximal Use Systemic Exposure Study of Levulan Kerastick (MUSE 2)
- Bilateral Comparison of Treatment of Facial Actinic Keratoses Using Microneedling and Photodynamic Therapy With Aminolevulinic Acid and Blue Light Versus Photodynamic Therapy With Aminolevulinic Acid and Blue Light Using Two Incubation Times
- The Use of Microneedles to Expedite Treatment Time in Photodynamic Therapy
- Daylight PDT for Actinic Keratoses: a Multicentre Study Comparing Two Photosensitizers (BF-200 ALA Versus MAL)
- A Clinical Trial Evaluating the Role of Systemic Antihistamine Therapy in the Reduction of Adverse Effects Associated With Topical 5-aminolevulinic Acid Photodynamic Therapy
- Impact of iMRI on the Extent of Resection in Patients With Newly Diagnosed Glioblastomas
- Superficial Basal Cell Cancer's Photodynamic Therapy: Comparing Three Photosensitizers: HAL and BF-200 ALA Versus MAL
- Maximal Use Systemic Exposure (MUSE) Study of Levulan Kerastick
- Blue vs Red Light During Levulan Based Photodynamic Therapy in Patients With Basal Cell Nevus Syndrome
- Controlled Study of the Occurrence of Actinic Keratosis on the Face After Cryotherapy + Aminolevulinic Acid (ALA) Photodynamic Therapy
- Blue vs Red Light During Levulan Based Photodynamic Therapy in Patients With Basal Cell Nevus Syndrome
- Safety and Efficacy Study for the Treatment of Non-Aggressive Basal Cell Carcinoma With Photodynamic Therapy
- A Laser Detection for Bladder Cancer by (Photodynamic) Spectra of Urine
- Photodynamic Therapy for Papulopustular Rosacea
- The Use of 5-aminolevulinic Acid (ALA) as an Intraoperative Tumor Marker for Resection of Pediatric Central Nervous System (CNS) Tumors
- Study of Methyl Aminolaevulinate Photodynamic Therapy With and Without Er:YAG Laser in Bowen's Disease
- Daylight-PDT for AKs: Comparing Two Photosensitizers (BF-200 ALA and MAL)
- The Use of Microneedles in Photodynamic Therapy
- MEDICO-ECONOMIC EVALUATION OF SURGERY GUIDED BY FLUORESCENCE FOR THE OPTIMIZATION OF RESECTION OF GLIOBLASTOMAS
- Photodynamic Therapy for Ulcerative Colitis
- Reduced Side-Effects Of Photodynamic Therapy For The Treatment Of Moderate To Severe Acne (i-PDT)
- Phase I Photodynamic Therapy (PDT) for Benign Dermal Neurofibromas (NF1)
- A Proof of Principle Study of Aminolevulinic Acid (ALA) - Induced Fluorescence Detection in Resectable Non-Small Cell Lung Cancer
- Aminolevulinic Acid in Visualizing a Tumor During Surgery in Patients With Glioblastoma Multiforme
- Effect of Isoniazid on Protoporphyrin Levels in Erythropoietic Protoporphyria
- Phase I Study of Orally Administered Aminolevulinic Acid for Resection of Malignant Astrocytomas
- Fluorescence-guided Surgery for Low- and High-grade Gliomas
- Superficial Basal Cell Carcinoma Treatment With Topical Photodynamic Therapy With Fractionated 5-aminolevulinic Acid 20% Versus Two Stage Methylaminolevulinate
- Comparison Between 5-aminolevulinic Acid Photodynamic Therapy Versus Cryotherapy for Actinic Keratosis Treatment
- More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery
- A Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Malignant Glial Tumors of the Brain
- A Study of Aminolevulinic Acid Used to Enhance Visualization and Surgical Removal of Brain Tumors
- Photodynamic Therapy Compared to Adapalene 0.1% Gel Plus Doxycycline in the Treatment of Acne Vulgaris
- Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy
- Study of NPC-07 for Fluorescence-guided Resection of Malignant Gliomas
- Aminolevulinic Acid During Surgery in Treating Patients With Malignant Brain Tumors
- A Study of the Specificity and Sensitivity of 5- Aminolevulinic Acid (ALA) Fluorescence in Malignant Brain Tumors
- Safety Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Tumors of the Brain
- Photodynamic Therapy With Levulan® +/- Topical Retinoid Pre-Treatment In The Treatment Of Actinic Keratoses
- Photodynamic Therapy in Treating Patients With Premalignant or Early Stage Head and Neck Tumors
- Photodynamic Therapy in Treating Patients With Premalignant or Early Stage Head and Neck Tumors
- A Study of the Specificity and Sensitivity of 5-ALA Fluorescence in Malignant Brain Tumors
- Safety Study of Aminolevulinic Acid (ALA) to Improve Visibility of Brain Tumors During Surgery
- ALA-PDT Versus Vehicle PDT for Treatment of AK and Reduction of New NMSC in Solid Organ Transplant Recipients
- Imaging Procedure Using ALA in Finding Residual Tumor in Grade IV Malignant Astrocytoma
- Photodynamic Therapy Using Aminolevulinic Acid in Treating Patients With Skin Cancer
- Light Dose Ranging Study of Photodynamic Therapy (PDT) With Levulan + Blue Light Versus Vehicle + Blue Light in Severe Facial Acne
- Study of Aminolevulinic Acid to Enhance Visualization and Resection of Malignant Glial Tumors of the Brain
- Topical Aminolevulinic Acid in Patients With Nonmelanoma Skin Cancer
- Treatment of Oral Premalignant Lesions With 5-ALA PDT
- Photodynamic Therapy Using Aminolevulinic Acid in Treating Patients With Oral Leukoplakia
- Photodynamic Therapy Using Topical Aminolevulinic Acid in Treating Patients With Actinic Keratosis
- Phase 2, Open-Label, Multi-Dose Study of Panhematin in Patients With MDS
- Fluorescence-guided Resection of Malignant Gliomas With 5-Aminolevulinic Acid
- Photodynamic Therapy in Treating Patients With Lymphoma or Chronic Lymphocytic Leukemia
- Photodynamic Therapy in Treating Patients With Skin Cancer
- Photodynamic Therapy in Treating Patients With Skin Cancer
Clinical trials list
click for details